Treatment with EA extract reduced the number of proliferating HER2-positive breast cancer cells in a dose-dependent manner (Figure 1); notably, concentrations of 100 and 200 μL/mL showed a substantial decrease in cell viability of SKBR3 and ZR75-1 by 50% and 75%, respectively. The gene discussed is ERBB2; the disease is breast carcinoma.